ENZON PHARMACEUTICALS, INC. Quarterly Return On Assets in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Enzon Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q2 2024.
  • Enzon Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2024 was 3.37 %, a 127% increase year-over-year.
  • Enzon Pharmaceuticals, Inc. annual Return On Assets for 2023 was 2.92 %.
  • Enzon Pharmaceuticals, Inc. annual Return On Assets for 2022 was -0.39 %, a 59.4% increase from 2021.
  • Enzon Pharmaceuticals, Inc. annual Return On Assets for 2021 was -0.98 %, a 87.6% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 3.37 +1.89 +127% Apr 1, 2024 Jun 30, 2024
Q1 2024 3.18 +2.54 +396% Jan 1, 2024 Mar 31, 2024
Q4 2023 2.92 +3.32 Oct 1, 2023 Dec 31, 2023
Q3 2023 2.2 +3.79 Jul 1, 2023 Sep 30, 2023
Q2 2023 1.49 +3.51 Apr 1, 2023 Jun 30, 2023
Q1 2023 0.64 +2.25 Jan 1, 2023 Mar 31, 2023
Q4 2022 -0.39 +0.58 +59.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -1.59 -0.22 -16.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -2.03 +0.21 +9.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -1.61 +2.29 +58.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -0.98 +6.93 +87.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -1.37 +17.3 +92.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -2.23 +11.6 +83.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -3.91 +5.24 +57.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -7.91 +1.09 +12.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -18.7 -65.6 -140% Jul 1, 2020 Sep 30, 2020
Q2 2020 -13.8 -62.4 -129% Apr 1, 2020 Jun 30, 2020
Q1 2020 -9.14 -59.7 -118% Jan 1, 2020 Mar 31, 2020
Q4 2019 -9 -64 -116% Oct 1, 2019 Dec 31, 2019
Q3 2019 46.9 +53.2 Jul 1, 2019 Sep 30, 2019
Q2 2019 48.5 +47.4 +4287% Apr 1, 2019 Jun 30, 2019
Q1 2019 50.5 +9.21 +22.3% Jan 1, 2019 Mar 31, 2019
Q4 2018 55 +7.12 +14.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 -6.25 -9.37 -300% Jul 1, 2018 Sep 30, 2018
Q2 2018 1.11 -6.58 -85.6% Apr 1, 2018 Jun 30, 2018
Q1 2018 41.3 +53.6 Jan 1, 2018 Mar 31, 2018
Q4 2017 47.9 +54 Oct 1, 2017 Dec 31, 2017
Q3 2017 3.12 -71.9 -95.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 7.69 -54.6 -87.7% Apr 1, 2017 Jun 30, 2017
Q1 2017 -12.3 -72.9 -120% Jan 1, 2017 Mar 31, 2017
Q4 2016 -6.11 -76.2 -109% Oct 1, 2016 Dec 31, 2016
Q3 2016 75 +30.9 +70% Jul 1, 2016 Sep 30, 2016
Q2 2016 62.3 -5.56 -8.19% Apr 1, 2016 Jun 30, 2016
Q1 2016 60.6 -27.9 -31.5% Jan 1, 2016 Mar 31, 2016
Q4 2015 70.1 -43.4 -38.2% Oct 1, 2015 Dec 31, 2015
Q3 2015 44.1 -111 -71.5% Jul 1, 2015 Sep 30, 2015
Q2 2015 67.9 -89.8 -56.9% Apr 1, 2015 Jun 30, 2015
Q1 2015 88.5 -68.6 -43.7% Jan 1, 2015 Mar 31, 2015
Q4 2014 114 +84.3 +289% Oct 1, 2014 Dec 31, 2014
Q3 2014 155 +148 +2175% Jul 1, 2014 Sep 30, 2014
Q2 2014 158 +154 +4552% Apr 1, 2014 Jun 30, 2014
Q1 2014 157 +157 +59170% Jan 1, 2014 Mar 31, 2014
Q4 2013 29.2 +30.1 Oct 1, 2013 Dec 31, 2013
Q3 2013 6.81 +7.62 Jul 1, 2013 Sep 30, 2013
Q2 2013 3.39 +8.1 Apr 1, 2013 Jun 30, 2013
Q1 2013 0.26 +6.53 Jan 1, 2013 Mar 31, 2013
Q4 2012 -0.96 Oct 1, 2012 Dec 31, 2012
Q3 2012 -0.81 Jul 1, 2012 Sep 30, 2012
Q2 2012 -4.71 Apr 1, 2012 Jun 30, 2012
Q1 2012 -6.27 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.